Interphase cytogenetic analysis with centromeric probes for chromosomes 1, 2, 6, 10, and 17 in 11 tumors from a patient with bilateral renal oncocytosis

Modern Pathology

Volumn 21, Issue 4, 2008, Pages 498-504

  Cossu Rocca, Paolo ^a,b   Eble, John N ^a   Zhang, Shaobo ^a   Bonsib, Stephen M ^c   Martignoni, Guido ^d   Brunelli, Matteo ^b   Cheng, Liang ^a,e  

^a INDIANA UNIVERSITY   (United States)

^b UNIVERSITY OF SASSARI   (Italy)

^c LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^d UNIVERSITY OF VERONA   (Italy)

^e INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Fluorescence in situ hybridization; Kidney; Renal oncocytosis

Indexed keywords

ADULT; ANAMNESIS; ARTICLE; CANCER DIAGNOSIS; CASE REPORT; CENTROMERE; CHROMOSOME 1; CHROMOSOME 10; CHROMOSOME 17; CHROMOSOME 2; CHROMOSOME 6; CHROMOSOME ANALYSIS; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; DNA HYBRIDIZATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERPHASE; KIDNEY CARCINOMA; KIDNEY PARENCHYMA; KIDNEY TUBULE; KIDNEY TUMOR; ONCOCYTOMA; PRIORITY JOURNAL; RENAL ONCOCYTOSIS;

ADENOMA, OXYPHILIC; CARCINOMA, RENAL CELL; CENTROMERE; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 10; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 2; CHROMOSOMES, HUMAN, PAIR 6; CYTOGENETIC ANALYSIS; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERPHASE; KIDNEY NEOPLASMS; MIDDLE AGED;

EID: 41149139026     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2008.16     Document Type: Article

References (35)

1. Reid R, Banerjee SS, Sciot R. Giant cell tumour. In: Fletcher CDM, Unni KK, Mertens F (eds). Pathology & Genetics: Tumours of Soft Tissue and Bone. IARC Press: Lyon, 2002, pp 310-312.
2. Mendenhall WM, Zlotecki RA, Scarborough MT, et al. Giant cell tumor of bone. Am J Clin Oncol 2006;29:96-99.
3. Kauzman A, Li SQ, Bradley G, et al. Cyclin alterations in giant cell tumor of bone. Mod Pathol 2003;16:210-218.
4. Kandel R, Li SQ, Bell R, et al. Cyclin D1 and p21 is elevated in the giant cells of giant cell tumors. J Orthop Res 2006;24:428-437.
5. Wu G, Nomoto S, Hoque MO, et al. DeltaNp63alpha and TAp63alpha regulate transcription of genes with distinct biological functions in cancer and development. Cancer Res 2003;63:2351-2357.
6. Dietz S, Rother K, Bamberger C, et al. Differential regulation of transcription and induction of programmed cell death by human p53-family members p63 and p73. FEBS Lett 2002;525:93-99.
7. Ross DA, Kadesch T. Consequences of Notch-mediated induction of Jagged1. Exp Cell Res 2004;296:173-182.
8. Yamada T, Yamazaki H, Yamane T, et al. Regulation of osteoclast development by Notch signaling directed to osteoclast precursors and through stromal cells. Blood 2003;101:2227-2234.
9. Moll UM, Slade N. p63 and p73: roles in development and tumor formation. Mol Cancer Res 2004;2:371-386.
10. Flores ER. The Roles of p63 in cancer. Cell Cycle 2007;6:300-304.
11. Yang A, Kaghad M, Wang Y, et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 1998;2:305-316.
12. Koker MM, Kleer CG. p63 expression in breast cancer: a highly sensitive and specific marker of metaplastic carcinoma. Am J Surg Pathol 2004;28:1506-1512.
13. Koga F, Kawakami S, Fujii Y, et al. Impaired p63 expression associates with poor prognosis and uroplakin III expression in invasive urothelial carcinoma of the bladder. Clin Cancer Res 2003;9:5501-5507.
14. Pelosi G, Pasini F, Olsen Stenholm C, et al. p63 immunoreactivity in lung cancer: yet another player in the development of squamous cell carcinomas? J Pathol 2002;198:100-109.
15. Unger P, Ewart M, Wang BY, et al. Expression of p63 in papillary thyroid carcinoma and in Hashimoto's thyroiditis: a pathobiologic link? Hum Pathol 2003;34:764-769.
16. Geddert H, Kiel S, Heep HJ, et al. The role of p63 and deltaNp63 (p40) protein expression and gene amplification in esophageal carcinogenesis. Hum Pathol 2003;34:850-856.
17. Di Como CJ, Urist MJ, Babayan I, et al. p63 expression profiles in human normal and tumor tissues. Clin Cancer Res 2002;8:494-501.
18. Brunner HG, Hamel BC, Bokhoven Hv H. P63 gene mutations and human developmental syndromes. Am J Med Genet 2002;112:284-290.
19. Park HR, Kim YW, Park JH, et al. Low expression of p63 and p73 in osteosarcoma. Tumori 2004;90:239-243.
20. Vincek V, Knowles J, Li J, et al. Expression of p63 mRNA isoforms in normal human tissue. Anticancer Res 2003;23:3945-3948.
21. Yamaguchi K, Wu L, Caballero OL, et al. Frequent gain of the p40/p51/p63 gene locus in primary head and neck squamous cell carcinoma. Int J Cancer 2000;86:684-689.
22. Massion PP, Taflan PM, Rahman SM, et al. Role of p63 amplification and overexpression in lung cancer development. Chest 2004;125:102S.
23. Vignery A. Macrophage fusion: the making of osteoclasts and giant cells. J Exp Med 2005;202:337-340.
24. Hosaka M, Hatori M, Smith R, et al. Giant cell formation through fusion of cells derived from a human giant cell tumor of tendon sheath. J Orthop Sci 2004;9:581-584.
25. Atkins GJ, Haynes DR, Graves SE, et al. Expression of osteoclast differentiation signals by stromal elements of giant cell tumors. J Bone Miner Res 2000;15:640-649.
26. Lau YS, Sabokbar A, Gibbons CL, et al. Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue. Hum Pathol 2005;36:945-954.
27. Kakizoe M. Apoptosis in giant cell tumors of bone. Kurume Med J 2000;47:125-134.
28. Huang L, Xu J, Li K, et al. Thapsigargin potentiates TRAIL-induced apoptosis in giant cell tumor of bone. Bone 2004;34:971-981.
29. Jung MS, Yun J, Chae HD, et al. p53 and its homologues, p63 and p73, induce a replicative senescence through inactivation of NF-Y transcription factor. Oncogene 2001;20:5818-5825.
30. Kauzman A, Li SQ, Bradley G, et al. Central giant cell granuloma of the jaws: assessment of cell cycle proteins. J Oral Pathol Med 2004;33:170-176.
31. Tse LL, Finkelstein SD, Siegler RW, et al. Osteoclast-type giant cell neoplasm of salivary gland. A microdissection-based comparative genotyping assay and literature review: extraskeletal "giant cell tumor of bone" or osteoclast-type giant cell "carcinoma"? Am J Surg Pathol 2004;28:953-961.
32. Rubin BP. Tenosynovial giant cell tumor and pigmented villonodular synovitis: a proposal for unification of these clinically distinct but histologically and genetically identical lesions. Skeletal Radiol 2007;36:267-268.
33. Ilaslan H, Sundaram M, Unni KK. Solid variant of aneurysmal bone cysts in long tubular bones: giant cell reparative granuloma. AJR Am J Roentgenol 2003;180:1681-1687.
34. Oda Y, Tsuneyoshi M, Shinohara N. 'Solid' variant of aneurysmal bone cyst (extragnathic giant cell reparative granuloma) in the axial skeleton and long bones. A study of its morphologic spectrum and distinction from allied giant cell lesions. Cancer 1992;70:2642-2649.
35. Rosenberg AE, Nielsen GP, Fletcher JA. Aneurysmal bone cyst. In: Fletcher CDM, Unni KK, Mertens F (eds). Pathology & Genetics: Tumours of Soft Tissue and Bone. IARC Press: Lyon, 2002, pp 338-339.